DTRACStudy design
The presentation introduces ReBloomLens for exercise and sleep self-management after breast cancer treatment. Eligibility is described as survivors in their 40s–60s who completed treatment for stage 0–3 breast cancer.
The design includes 40 participants: 20 intervention and 20 control, compared over four weeks. The planned intervention app-use period is 28 days. These figures are not reported here as completer counts or evidence of treatment effects.
Source: MD4BD presentation, September 17, 2026, pages 7 and 15.
Collection and participant experience
| Item | Presentation description |
|---|---|
| Devices | Galaxy phone and Galaxy Fit |
| Health records | Sleep, exercise, heart rate |
| Participant records | App entries and surveys |
| Purpose | Observe sleep regularity, exercise-guideline adherence, and routine practice |
The research configuration combines device records and app entries to support recovery of exercise and sleep habits. Not every record is an automatic wearable measurement.
App interface
This is the study-specific home UI shown in the presentation. It can differ from the repository's current default home screen.
Adapting the example
Review collection items, routines/questions, provider paths, participation period, and permissions for a new study. Copying the interface or study design does not establish suitability for a new population or equivalent effects. Outcome estimates are not supplied because they were not established by the provided presentation.